Trump nominates Dr. Heidi Overton to lead the FDA
Trump picked White House health aide Heidi Overton for FDA chief, drawing fire over abortion pills, vaccines and experience.
Objective Facts
Donald Trump said on August 19, 2026, that he will nominate Dr. Heidi Overton, a surgeon and deputy director of the White House Domestic Policy Council, to lead the Food and Drug Administration. She would fill the post Dr. Marty Makary left in May, and she needs Senate confirmation starting with the Health, Education, Labor and Pensions Committee chaired by Sen. Bill Cassidy (R-La.). Overton stood beside Trump on August 10 when he signed an executive order cutting the childhood vaccine schedule and backed offering measles, mumps and rubella vaccines as separate shots, NPR reported. She has written critically of medication abortion, and the AP reported that as commissioner she could roll back FDA rules that widened access to mifepristone. Cassidy raised concerns, Sen. Patty Murray (D-Wash.) said she would vote no, and anti-abortion groups praised the choice.
Left-Leaning Perspective
NPR's Sydney Lupkin focused on Overton's vaccine record and past policy writing. She quoted former FDA principal deputy commissioner Dr. Joshua Sharfstein, who called the commissioner job possibly the hardest health post in government and said public health experts see no scientific basis for splitting the MMR shot. CBS News led with Cassidy's objections alongside Trump's praise, and Civil Eats reporter Rebekah Alvey tied the pick to a record cyclospora outbreak and to MAHA activists who said the nominee was too close to the pesticide industry.
Right-Leaning Perspective
Fox News reporter James Cirrone presented Overton as a physician with close ties to the White House and HHS, leading with Trump's praise and her role in the August 10 vaccine order. The Fox piece tied her 2023 criticism of chemical abortion to the FDA's authority over mifepristone and did not include critics. The Daily Signal, in a story by Virginia Grace McKinnon reprinted by LifeNews, reported early praise from MAHA figures and anti-abortion leaders, and quoted Sen. Josh Hawley (R-Mo.) calling the news welcome.
Deep Dive
The FDA has lacked a confirmed leader since Marty Makary resigned in May after 13 months marked by complaints from drug industry executives and anti-abortion activists, the AP reported. Trump turned to Heidi Overton, a surgeon who moved from the America First Policy Institute to the White House Domestic Policy Council and who appeared at his drug pricing and vaccine events. Her nomination arrived nine days after Trump's August 10 executive order trimming the childhood vaccine schedule, during a cyclospora outbreak that Civil Eats counted at more than 15,000 confirmed cases. Critics on the left are right that Overton's written record on medication abortion is clear and that the FDA controls mifepristone rules; the AP and Fox News both reported her past criticism. Their coverage gives less attention to her clinical research training at Johns Hopkins. Supporters stress her loyalty and her closeness to Kennedy and Mehmet Oz, but Fox News and LifeSiteNews said little about the management concerns raised by Cassidy, a Republican who controls the committee that will hear her nomination. The early MAHA objections from Kelly Ryerson and Alex Clark show that resistance is not confined to Democrats. The next step is a HELP Committee hearing after senators return from the August recess; Civil Eats reported that no date had been set. Cassidy did not say how he would vote, NPR reported, and his panel's vote will matter for her path to the floor. Questions on mifepristone, the vaccine order and food safety funding are likely to dominate, and anti-abortion leaders have already signaled what they expect from her on the abortion pill.